Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Merck
Boehringer Ingelheim
Healthtrust
UBS
AstraZeneca

Generated: May 26, 2019

DrugPatentWatch Database Preview

Litigation Details for Gilead Sciences v. Sigmapharm Labs (Fed. Cir. 2014)

« Back to Dashboard

Small Molecule Drugs cited in Gilead Sciences v. Sigmapharm Labs
The small molecule drugs covered by the patents cited in this case are ➤ Sign Up and ➤ Sign Up .
Biologic Drugs cited in Gilead Sciences v. Sigmapharm Labs
The biologic drug covered by the patents cited in this case is ➤ Sign Up .

Details for Gilead Sciences v. Sigmapharm Labs (Fed. Cir. 2014)

Date Filed Document No. Description Snippet Link To Document
2014-07-10 25 EXAMPLE45 1=10). 66.17 (C-4'. d. J=1S9), 43.12 (C-1'). lR (KBr…the FDA that the ’340 patent and U.S. Patent No. 5,663,159 (“the ’159 patent”), listed in the U.S.…States patents assigned or licensed to Gilead, namely U.S. Patent No. 5,663,159 (“the ’159 patent”) and… infringement of the ’159 patent and the ’340 patent (collectively “Patents-In-Suit”), as well as …The ’159 Patent With respect to the ’159 patent, Sigmapharm contends that the patent was invalid External link to document
2014-08-21 31 position with respect to U.S. Patent No. 6,451,340 (the “’340 Patent”) was anything other than a …infringe the ’159 Patent or the ’340 Patent, and alleging that the ’159 Patent was invalid. On …infringing claims of U.S. Patent Nos. 6,848,072 (the ’072 patent), 7,028,244 (the ’244 patent), …listed United States patents assigned or licensed to Gilead, namely ’159 Patent claims AD and expires…of certain asserted claims of the ’159 Patent (i.e., the patent covering, inter alia, the compound External link to document
Date Filed Document No. Description Snippet Link To Document

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Medtronic
Johnson and Johnson
Chinese Patent Office
Covington
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.